Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, ISEC Healthcare's Enterprise Value is S$201.06 Mil.
ISEC Healthcare's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 was S$17.69 Mil. Therefore, ISEC Healthcare's EV-to-EBIT ratio for today is 11.37.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, ISEC Healthcare's Enterprise Value is S$201.06 Mil.
ISEC Healthcare's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 was S$22.19 Mil. Therefore, ISEC Healthcare's EV-to-EBITDA ratio for today is 9.06.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, ISEC Healthcare's Enterprise Value is S$201.06 Mil.
ISEC Healthcare's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 was S$75.14 Mil. Therefore, ISEC Healthcare's EV-to-Revenue ratio for today is 2.68.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, ISEC Healthcare's Enterprise Value is S$201.06 Mil.
ISEC Healthcare's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2025 was S$7.79 Mil. Therefore, ISEC Healthcare's EV-to-FCF ratio for today is 25.80.
ISEC Healthcare Enterprise Value Historical Data
The historical data trend for ISEC Healthcare's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of ISEC Healthcare's Enterprise Value
For the Medical Care Facilities subindustry, ISEC Healthcare's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ISEC Healthcare's Enterprise Value Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, ISEC Healthcare's Enterprise Value distribution charts can be found below:
* The bar in red indicates where ISEC Healthcare's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
ISEC Healthcare's Enterprise Value for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ISEC Healthcare (SGX:40T) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
ISEC Healthcare's current Enterprise Value is S$201.06 Mil.
ISEC Healthcare's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was S$17.69 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
ISEC Healthcare's current Enterprise Value is S$201.06 Mil.
ISEC Healthcare's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was S$22.19 Mil.
ISEC Healthcare's current Enterprise Value is S$201.06 Mil.
ISEC Healthcare's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was S$75.14 Mil.
ISEC Healthcare's current Enterprise Value is S$201.06 Mil.
ISEC Healthcare's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was S$7.79 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ISEC Healthcare Enterprise Value Related Terms
Thank you for viewing the detailed overview of ISEC Healthcare's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
ISEC Healthcare Ltd is a Singapore based company engaged in providing medical eye care services through its subsidiaries. It also provides ambulatory surgical centers. In addition, the group is also focused on offering general medical services and aesthetic treatment services. The company has two reportable segments, namely Specialized health services, which include the provision of medical care, consultancy, treatment and surgery in the field of ophthalmology; and General health services which includes the provision of general medical and procedural treatment services It generates maximum revenue from the specialized health services segment. The firm operates in Singapore and Malaysia, of which key revenue is derived from Malaysia.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SGX:40T has been successfully added to your 